|
...13% year-over-year
-- Record Cordis and non-Cordis revenue, with non-Cordis revenue growing faster sequentially than Cordis revenue
-- GAAP results:
-- Operating income $9.0 million
-- Net income of $1.5 million
-- Diluted EPS of $0.08
-- Non-GAAP results (excluding non-cash equity compensation expense and a non-cash impairment loss on the company's investment in Novocell):
-- Record operating income of $10.5 million
-- Record net income of $7.2 million
-- Record diluted EPS of $0.38
-- Seven new licenses signed with SurModics customers
-- Record CYPHER sales of $717 million
-- 7th consecutive quarter of record non-GAAP net income
-- 8th consecutive quarter with non-Cordis revenue exceeding Cordis revenue
"SurModics is pleased to report strong financial and operating results for the second quarter of fiscal year...
NOTE: All illustrations and photos
have been removed from this article.
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
